IS2783B - Lyfjasamsetning sem nær yfir kító-fáliður - Google Patents
Lyfjasamsetning sem nær yfir kító-fáliðurInfo
- Publication number
- IS2783B IS2783B IS7193A IS7193A IS2783B IS 2783 B IS2783 B IS 2783B IS 7193 A IS7193 A IS 7193A IS 7193 A IS7193 A IS 7193A IS 2783 B IS2783 B IS 2783B
- Authority
- IS
- Iceland
- Prior art keywords
- oligomers
- chitosomes
- covers
- pharmaceutical composition
- treatment
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000012659 Joint disease Diseases 0.000 abstract 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
- 229920002101 Chitin Polymers 0.000 abstract 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 1
- 230000006196 deacetylation Effects 0.000 abstract 1
- 238000003381 deacetylation reaction Methods 0.000 abstract 1
- 229960002442 glucosamine Drugs 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS6085A IS6085A (is) | 2001-09-26 | 2001-09-26 | Lyfjablanda með kítósan óligómerum |
| PCT/IS2002/000016 WO2003026677A1 (en) | 2001-09-26 | 2002-09-26 | Pharmaceutical composition comprising chito-oligomers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS7193A IS7193A (is) | 2004-03-22 |
| IS2783B true IS2783B (is) | 2012-05-15 |
Family
ID=36700489
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS6085A IS6085A (is) | 2001-09-26 | 2001-09-26 | Lyfjablanda með kítósan óligómerum |
| IS7193A IS2783B (is) | 2001-09-26 | 2004-03-22 | Lyfjasamsetning sem nær yfir kító-fáliður |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS6085A IS6085A (is) | 2001-09-26 | 2001-09-26 | Lyfjablanda með kítósan óligómerum |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7985741B2 (is) |
| EP (1) | EP1435976B1 (is) |
| JP (1) | JP4613008B2 (is) |
| KR (1) | KR20040062548A (is) |
| AT (1) | ATE359797T1 (is) |
| CA (1) | CA2507926C (is) |
| DE (1) | DE60219653T2 (is) |
| DK (1) | DK1435976T3 (is) |
| ES (1) | ES2284935T3 (is) |
| IS (2) | IS6085A (is) |
| PT (1) | PT1435976E (is) |
| SI (1) | SI1435976T1 (is) |
| WO (1) | WO2003026677A1 (is) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050070500A1 (en) * | 2001-12-13 | 2005-03-31 | Boucher L Isabelle | Method of modulating release of saccharides and uses thereof |
| GB0321996D0 (en) * | 2003-09-19 | 2003-10-22 | Novartis Nutrition Ag | Organic compounds |
| JP2007507516A (ja) * | 2003-10-01 | 2007-03-29 | オプティマー・ファーマスーティカルズ・インコーポレイテッド | アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用 |
| CA2546861A1 (en) * | 2003-11-24 | 2005-06-09 | Optimer Pharmaceuticals, Inc. | Treatment of a condition in a mammal with administration of compounds and methods of use thereof |
| WO2005112948A1 (ja) * | 2004-05-21 | 2005-12-01 | Tottori University | 創傷の治療又は処置のための薬剤 |
| HUE035956T2 (en) * | 2005-06-14 | 2018-05-28 | Genis Hf | Preparations of partially deacetylated chitin derivatives |
| WO2007001282A2 (en) * | 2005-06-16 | 2007-01-04 | E.I. Dupont De Nemours And Company | Low molecular weight polyglucosamines and polygalactosamines |
| US7485718B2 (en) | 2005-06-16 | 2009-02-03 | E. I. Du Pont De Nemours And Company | Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines |
| KR100831335B1 (ko) * | 2006-06-22 | 2008-05-22 | 부경대학교 산학협력단 | 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제 |
| CN102159218B (zh) * | 2008-07-18 | 2015-12-02 | 杰尼斯Ehf公司 | 用于医学用途的新型几丁低聚物组合物 |
| KR20100060634A (ko) * | 2008-11-28 | 2010-06-07 | (주)아모레퍼시픽 | 미토콘드리아 활성화를 위한 조성물 |
| KR101729137B1 (ko) * | 2009-07-28 | 2017-04-26 | (주)아모레퍼시픽 | 키토올리고당을 함유하는 피로회복용 조성물 |
| WO2012167226A2 (en) | 2011-06-03 | 2012-12-06 | Maguire Abbey, Llc | Method, composition, and articles for improving joint lubrication |
| PL2747565T3 (pl) | 2011-09-08 | 2017-09-29 | Novozymes Bioag A/S | Sposoby zaprawiania nasion |
| CA2848856C (en) | 2011-09-14 | 2020-04-28 | Novozymes Bioag A/S | Use of lipochito-oligosaccharides and/or chito-oligosaccharides in combination with phosphate-solubilizing microorganisms to enhance plant growth |
| US9055746B2 (en) | 2011-09-23 | 2015-06-16 | Novozymes Bioag A/S | Chitooligosaccharides and methods for use in enhancing plant growth |
| IN2014CN02911A (is) * | 2011-09-23 | 2015-07-03 | Novozymes Bioag As | |
| DK2841114T3 (en) | 2012-04-23 | 2018-09-24 | Genis Hf | SELF-HARDING BIOACTIVE CEMENT COMPOSITIONS WITH PARTIAL DEACETYLATED CHITIN AS BONE TRANSPLANT REPLACEMENTS |
| JP6285497B2 (ja) * | 2016-06-07 | 2018-02-28 | 株式会社エバーライフ | 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法 |
| KR101673368B1 (ko) | 2016-07-14 | 2016-11-08 | 김기혁 | 공정가스 반응물의 콜드트랩 장치 |
| WO2023205718A2 (en) * | 2022-04-21 | 2023-10-26 | Hassan Ameer E | Methods of treating inflammation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5919122B2 (ja) * | 1976-10-12 | 1984-05-02 | 味の素株式会社 | 水溶性部分脱アセチル化キチン及びその製造法 |
| US4532134A (en) * | 1981-04-06 | 1985-07-30 | Malette William Graham | Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound |
| JP2527317B2 (ja) * | 1986-12-19 | 1996-08-21 | ライオン株式会社 | 骨疾患治療剤 |
| US6184037B1 (en) * | 1996-05-17 | 2001-02-06 | Genemedicine, Inc. | Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell |
| EP0957925B1 (en) * | 1996-12-13 | 2005-04-20 | Lescarden, Inc. | Treatment of osteoarthritis by administering poly-n-acetyl-d-glucosamine |
| JP3062592B2 (ja) * | 1997-05-30 | 2000-07-10 | 農林水産省食品総合研究所長 | ２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法 |
| US6492350B2 (en) * | 2000-01-27 | 2002-12-10 | Jdc (Hawaii) Inc. | Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain |
| EP1127574A1 (en) * | 2000-02-22 | 2001-08-29 | Food Industry Research and Development Institute | Use of chitinous materials for inhibiting cellular nitric oxide production |
| CA2313836C (en) * | 2000-03-15 | 2009-06-09 | Cargill, Incorporated | Chitosan and method of preparing chitosan |
| US20020119949A1 (en) * | 2001-02-26 | 2002-08-29 | Asa Hellman | Prophylactic teat treatment |
| HUE035956T2 (en) * | 2005-06-14 | 2018-05-28 | Genis Hf | Preparations of partially deacetylated chitin derivatives |
-
2001
- 2001-09-26 IS IS6085A patent/IS6085A/is unknown
-
2002
- 2002-09-26 JP JP2003530312A patent/JP4613008B2/ja not_active Expired - Lifetime
- 2002-09-26 ES ES02777769T patent/ES2284935T3/es not_active Expired - Lifetime
- 2002-09-26 SI SI200230558T patent/SI1435976T1/sl unknown
- 2002-09-26 CA CA2507926A patent/CA2507926C/en not_active Expired - Lifetime
- 2002-09-26 KR KR10-2004-7004323A patent/KR20040062548A/ko not_active Ceased
- 2002-09-26 US US10/490,637 patent/US7985741B2/en active Active
- 2002-09-26 DE DE60219653T patent/DE60219653T2/de not_active Expired - Lifetime
- 2002-09-26 WO PCT/IS2002/000016 patent/WO2003026677A1/en not_active Ceased
- 2002-09-26 AT AT02777769T patent/ATE359797T1/de active
- 2002-09-26 PT PT02777769T patent/PT1435976E/pt unknown
- 2002-09-26 EP EP02777769A patent/EP1435976B1/en not_active Expired - Lifetime
- 2002-09-26 DK DK02777769T patent/DK1435976T3/da active
-
2004
- 2004-03-22 IS IS7193A patent/IS2783B/is unknown
-
2011
- 2011-06-20 US US13/164,397 patent/US8415326B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE359797T1 (de) | 2007-05-15 |
| CA2507926A1 (en) | 2003-04-03 |
| EP1435976B1 (en) | 2007-04-18 |
| DK1435976T3 (da) | 2007-08-27 |
| WO2003026677A1 (en) | 2003-04-03 |
| US8415326B2 (en) | 2013-04-09 |
| US7985741B2 (en) | 2011-07-26 |
| CA2507926C (en) | 2011-12-20 |
| US20110257381A1 (en) | 2011-10-20 |
| JP2005507891A (ja) | 2005-03-24 |
| JP4613008B2 (ja) | 2011-01-12 |
| US20050004073A1 (en) | 2005-01-06 |
| DE60219653D1 (de) | 2007-05-31 |
| DE60219653T2 (de) | 2008-01-03 |
| SI1435976T1 (sl) | 2007-08-31 |
| KR20040062548A (ko) | 2004-07-07 |
| PT1435976E (pt) | 2007-06-28 |
| EP1435976A1 (en) | 2004-07-14 |
| ES2284935T3 (es) | 2007-11-16 |
| IS6085A (is) | 2003-03-27 |
| IS7193A (is) | 2004-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS2783B (is) | Lyfjasamsetning sem nær yfir kító-fáliður | |
| CA2303498A1 (en) | Dioxocyclopentyl hydroxamic acids | |
| WO2004105737A3 (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
| EP2497478A3 (en) | Oligosaccaride compositions and use thereof in the treatment of infection | |
| PT1319183E (pt) | Métodos e produtos relacionados a heparina de baixo peso molecular | |
| PT1420801E (pt) | Utilização de fucanos no tratamento de adesões, artrite e psoríase | |
| NO20012000D0 (no) | N-(2-aryl-propionyl)-sulfonamider og farmasöytiske sammensetninger som inneholder dem | |
| BR0010209A (pt) | Composições para o tratamento de desordens do esÈfago | |
| WO2003053359A3 (en) | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders | |
| NZ624749A (en) | A sulfated polysaccharide compound and the preparation and use thereof | |
| MY142376A (en) | Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them | |
| IL172773A (en) | Formulations for the treatment of arthritis conditions | |
| CA2474511A1 (en) | Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders | |
| IS6914A (is) | 2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum | |
| EE200100125A (et) | TAN-1057 derivaadid | |
| MXPA05005572A (es) | Esteres de acido aldonico, metodos para producir el mismo y metodos para producir ingredientes activos farmaceuticos acoplados a polisacaridos o derivados de polisacaridos en grupos de aminos libres. | |
| ITMI20021801A1 (it) | Prodotti di pomodoro. | |
| IT1318432B1 (it) | Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro | |
| BR9609416A (pt) | Agentes antivìrus. | |
| IT1314768B1 (it) | Processo per la produzione di additivi antifiamma per composizionipolimeriche,e prodotti ottenuti da detto processo | |
| EP1411956B8 (en) | Use of oversulfated polysaccharides as inhibitors of hiv | |
| FR2857026B1 (fr) | Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant | |
| ATE552004T1 (de) | Oral verabreichbare heparinderivate | |
| WO2000056298A3 (en) | Treatment of lyme disease with polysulfated glycosaminoglycan formulations | |
| WO2002068056A3 (en) | Combination comprising a 1,4-dioxonaphathalene compound and ribenoside |